{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:57:22Z","timestamp":1780963042273,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Clinical Research Funding","award":["BJ-2023-114"],"award-info":[{"award-number":["BJ-2023-114"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16073-4","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T22:43:47Z","timestamp":1777070627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Propensity score-matched evaluation of prophylactic hyperthermic intraperitoneal chemotherapy in geriatric patients with locally advanced colorectal cancer: safety and survival benefits"],"prefix":"10.1186","volume":"26","author":[{"given":"Min","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"3","key":"16073_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"1","key":"16073_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40122-024-00667-6","volume":"14","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Sun Q, Li J, Fu X, Wu Y, Zhang J, et al. The impact of ERAS and multidisciplinary teams on perioperative management in colorectal cancer. Pain therapy. 2025;14(1):201\u201315.","journal-title":"Pain therapy"},{"issue":"21","key":"16073_CR3","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1007\/s00018-015-1997-9","volume":"72","author":"EN Elliott","year":"2015","unstructured":"Elliott EN, Kaestner KH. Epigenetic regulation of the intestinal epithelium. Cell Mol Life Sci. 2015;72(21):4139\u201356.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"16073_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12876-022-02600-7","volume":"22","author":"T Gunji","year":"2022","unstructured":"Gunji T, Tomita K, Koganezawa I, Nakagawa M, Yokozuka K, Ochiai S, et al. Impact of atherosclerosis on the postoperative complications of colorectal surgery in older patients with colorectal cancer. BMC Gastroenterol. 2022;22(1):519.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"16073_CR5","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1007\/s00268-021-05985-w","volume":"45","author":"K Tomita","year":"2021","unstructured":"Tomita K, Koganezawa I, Nakagawa M, Ochiai S, Gunji T, Yokozuka K, et al. A new preoperative risk score for predicting postoperative complications in elderly patients undergoing hepatectomy. World J Surg. 2021;45(6):1868\u201376.","journal-title":"World J Surg"},{"issue":"3","key":"16073_CR6","doi-asserted-by":"publisher","first-page":"101558","DOI":"10.1016\/j.esmoop.2023.101558","volume":"8","author":"T Yoshino","year":"2023","unstructured":"Yoshino T, Cervantes A, Bando H, Martinelli E, Oki E, Xu RH, et al. Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer. ESMO open. 2023;8(3):101558.","journal-title":"ESMO open"},{"issue":"3","key":"16073_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, et al. Colon cancer, Version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN. 2021;19(3):329\u201359.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"4","key":"16073_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.6004\/jnccn.2022.0021","volume":"20","author":"RT Hoppe","year":"2022","unstructured":"Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, et al. NCCN Guidelines\u00ae Insights: Hodgkin Lymphoma, Version 2.2022. J Natl Compr Cancer Network: JNCCN. 2022;20(4):322\u201334.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"10","key":"16073_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","volume":"4","author":"CEL Klaver","year":"2019","unstructured":"Klaver CEL, Wisselink DD, Punt CJA, Snaebjornsson P, Crezee J, Aalbers AGJ, et al. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. lancet Gastroenterol Hepatol. 2019;4(10):761\u201370.","journal-title":"lancet Gastroenterol Hepatol"},{"issue":"2","key":"16073_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, Go\u00e9r\u00e9 D, Ghouti L, Pocard M, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366.","journal-title":"Lancet Oncol"},{"issue":"12","key":"16073_CR11","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database. Lancet Oncol. 2016;17(12):1709\u201319.","journal-title":"Lancet Oncol"},{"issue":"8","key":"16073_CR12","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1245\/s10434-018-6336-6","volume":"25","author":"RM Dodson","year":"2018","unstructured":"Dodson RM, Kuncewitch M, Votanopoulos KI, Shen P, Levine EA. Techniques for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018;25(8):2152\u20138.","journal-title":"Ann Surg Oncol"},{"key":"16073_CR13","doi-asserted-by":"crossref","unstructured":"Gronau F, Feldbruegge L, Oberwittler F, Gonzalez-Moreno S, Villeneuve L, Eveno C et al. HIPEC in peritoneal metastasis of gastric origin: a systematic review of regimens and techniques. J Clin Med. 2022;11(5):1456.","DOI":"10.3390\/jcm11051456"},{"issue":"3","key":"16073_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K, van Schagen JH, Schreuder HWR, Hermans RHM, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230\u201340.","journal-title":"N Engl J Med"},{"issue":"6","key":"16073_CR15","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575\u201381.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"16073_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","volume":"14","author":"J Esquivel","year":"2007","unstructured":"Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol. 2007;14(1):128\u201333.","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 5","key":"16073_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1245\/s10434-016-5519-2","volume":"23","author":"M Alyami","year":"2016","unstructured":"Alyami M, Lundberg P, Kepenekian V, Go\u00e9r\u00e9 D, Bereder JM, Msika S, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly: a case-controlled, multicenter study. Ann Surg Oncol. 2016;23(Suppl 5):737\u201345.","journal-title":"Ann Surg Oncol"},{"key":"16073_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.exger.2017.10.024","volume":"105","author":"G Pawelec","year":"2018","unstructured":"Pawelec G. Age and immunity: what is immunosenescence? Exp Gerontol. 2018;105:4\u20139.","journal-title":"Exp Gerontol"},{"key":"16073_CR19","doi-asserted-by":"crossref","unstructured":"Al Qahtani M, AlFulayyih SF, Al Baridi SS, Alomar SA, Alshammari AN, Albuaijan RJ et al. Exploring the impact of antibiotics on fever recovery time and hospital stays in children with viral infections: insights from advanced data analysis. Antibiotics (Basel, Switzerland). 2024;13(6):518.","DOI":"10.3390\/antibiotics13060518"},{"key":"16073_CR20","doi-asserted-by":"crossref","unstructured":"Qiu C, Li Y, Liang X, Qi Y, Chen Y, Meng X et al. A study of peritoneal metastatic xenograft model of colorectal cancer in the treatment of hyperthermic intraperitoneal chemotherapy with Raltitrexed. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie. 2017;92:149\u2009\u2013\u200956.","DOI":"10.1016\/j.biopha.2017.04.053"},{"issue":"4","key":"16073_CR21","first-page":"e58481","volume":"16","author":"K Adnan","year":"2024","unstructured":"Adnan K, Hussain S, Amir M, Ahmed S, Akbar A, Jadoon SK, et al. A clinical study of intraoperative perfusion chemotherapy with raltitrexed in colon cancer: a prospective cohort study. Cureus. 2024;16(4):e58481.","journal-title":"Cureus"},{"issue":"8","key":"16073_CR22","doi-asserted-by":"publisher","first-page":"110080","DOI":"10.1016\/j.ejso.2025.110080","volume":"51","author":"M Kazi","year":"2025","unstructured":"Kazi M, Ajith A, Bhatt A. The mitomycin versus oxaliplatin debate on HIPEC in colorectal cancers - an updated systematic review and meta-analysis. Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2025;51(8):110080.","journal-title":"Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"issue":"4","key":"16073_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/codi.13219","volume":"18","author":"J Segelman","year":"2016","unstructured":"Segelman J, Akre O, Gustafsson UO, Bottai M, Martling A. External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer. Colorectal disease: official J Association Coloproctology Great Br Irel. 2016;18(4):378\u201385.","journal-title":"Colorectal disease: official J Association Coloproctology Great Br Irel"},{"issue":"1","key":"16073_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12957-021-02374-4","volume":"19","author":"H Chen","year":"2021","unstructured":"Chen H, Zhou S, Bi J, Feng Q, Jiang Z, Xu J, et al. Does the primary tumour location affect the prognosis of patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? World J Surg Oncol. 2021;19(1):253.","journal-title":"World J Surg Oncol"},{"issue":"11","key":"16073_CR25","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1007\/s11605-023-05833-3","volume":"27","author":"H Benvenisti","year":"2023","unstructured":"Benvenisti H, Shiber M, Assaf D, Shovman Y, Laks S, Elbaz N, et al. Perioperative and oncological outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of rectal origin. J Gastrointest surgery: official J Soc Surg Aliment Tract. 2023;27(11):2506\u201314.","journal-title":"J Gastrointest surgery: official J Soc Surg Aliment Tract"},{"issue":"2","key":"16073_CR26","doi-asserted-by":"publisher","first-page":"109498","DOI":"10.1016\/j.ejso.2024.109498","volume":"51","author":"R Bri\u00e8re","year":"2025","unstructured":"Bri\u00e8re R, Simard AJ, Rouleau-Fournier F, Letarte F, Drolet S, Brind\u2019Amour A. Perioperative management and survival outcomes following cytoreductive surgery in patients with peritoneal metastases from rectal cancer: a scoping review. Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2025;51(2):109498.","journal-title":"Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"issue":"2","key":"16073_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/jso.23446","volume":"109","author":"JD Rivard","year":"2014","unstructured":"Rivard JD, McConnell YJ, Temple WJ, Mack LA. Cytoreduction and heated intraperitoneal chemotherapy for colorectal cancer: are we excluding patients who may benefit? J Surg Oncol. 2014;109(2):104\u20139.","journal-title":"J Surg Oncol"},{"issue":"2","key":"16073_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s13304-025-02104-5","volume":"77","author":"C Vallicelli","year":"2025","unstructured":"Vallicelli C, Morezzi D, Perrina D, Fugazzola P, Pinson J, Vigutto G, et al. Colon and rectal peritoneal carcinomatosis: are we mixing apples with oranges? A propensity score-matched analysis. Updates Surg. 2025;77(2):277\u201385.","journal-title":"Updates Surg"},{"issue":"5","key":"16073_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/bjs5.50179","volume":"3","author":"S Hallam","year":"2019","unstructured":"Hallam S, Tyler R, Price M, Beggs A, Youssef H. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. BJS open. 2019;3(5):585\u201394.","journal-title":"BJS open"},{"issue":"11","key":"16073_CR30","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1016\/j.asjsur.2024.03.143","volume":"47","author":"T Mo","year":"2024","unstructured":"Mo T, Wen X, Hu T, Zhang Z, Shi Y, Chen Y, et al. The safety and effectiveness of prophylactic hyperthermic intraperitoneal chemotherapy in patients with pathological T3-4 locally advanced colon cancer. Asian J Surg. 2024;47(11):4717\u201324.","journal-title":"Asian J Surg"},{"issue":"2","key":"16073_CR31","doi-asserted-by":"publisher","first-page":"107958","DOI":"10.1016\/j.ejso.2024.107958","volume":"50","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Zhang J, Chen C, Gong Z, Wang Z, Deng Q, et al. Prophylactic hyperthermic intraperitoneal chemotherapy in T4 colorectal cancer: can it improve the oncologic prognosis? - A propensity score matching study. Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2024;50(2):107958.","journal-title":"Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"issue":"7","key":"16073_CR32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamasurg.2023.0662","volume":"158","author":"A Arjona-S\u00e1nchez","year":"2023","unstructured":"Arjona-S\u00e1nchez A, Espinosa-Redondo E, Guti\u00e9rrez-Calvo A, Segura-Sampedro JJ, P\u00e9rez-Viejo E, Concepci\u00f3n-Mart\u00edn V, et al. Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced colon cancer: a phase 3 randomized clinical trial. JAMA Surg. 2023;158(7):683\u201391.","journal-title":"JAMA Surg"},{"issue":"9","key":"16073_CR33","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1093\/annonc\/mdv285","volume":"26","author":"F Sclafani","year":"2015","unstructured":"Sclafani F, Chau I, Cunningham D, Peckitt C, Lampis A, Hahne JC, et al. Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial. Annals oncology: official J Eur Soc Med Oncol. 2015;26(9):1936\u201341.","journal-title":"Annals oncology: official J Eur Soc Med Oncol"},{"issue":"4","key":"16073_CR34","first-page":"390","volume":"29","author":"C Dervenis","year":"2016","unstructured":"Dervenis C, Xynos E, Sotiropoulos G, Gouvas N, Boukovinas I, Agalianos C, et al. Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Annals Gastroenterol. 2016;29(4):390\u2013416.","journal-title":"Annals Gastroenterol"},{"issue":"1","key":"16073_CR35","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.jss.2012.01.015","volume":"179","author":"K Votanopoulos","year":"2013","unstructured":"Votanopoulos K, Ihemelandu C, Shen P, Stewart J, Russell G, Levine EA. A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C. J Surg Res. 2013;179(1):e133\u20139.","journal-title":"J Surg Res"},{"issue":"4","key":"16073_CR36","first-page":"254","volume":"14","author":"F Liu","year":"2011","unstructured":"Liu F, Yu J, Liang YZ, Hu YF, Wang YN, Li GX. [Associated risk factors of peritoneal metastasis in colorectal cancer]. Zhonghua wei chang wai ke za zhi\u2009=\u2009Chinese. J Gastrointest Surg. 2011;14(4):254\u20136.","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"16073_CR37","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1245\/s10434-018-6628-x","volume":"25","author":"EJ Park","year":"2018","unstructured":"Park EJ, Ahn J, Gwak SW, Park KS, Baik SH, Hwang SJ. Pharmacologic properties of the carrier solutions for hyperthermic intraperitoneal chemotherapy: comparative analyses between water and lipid carrier solutions in the rat model. Ann Surg Oncol. 2018;25(11):3185\u201392.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"16073_CR38","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/jso.24169","volume":"113","author":"GA Simkens","year":"2016","unstructured":"Simkens GA, van Oudheusden TR, Braam HJ, Wiezer MJ, Nienhuijs SW, Rutten HJ, et al. Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study. J Surg Oncol. 2016;113(5):548\u201353.","journal-title":"J Surg Oncol"},{"issue":"6","key":"16073_CR39","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ejso.2016.03.014","volume":"42","author":"GA Simkens","year":"2016","unstructured":"Simkens GA, Razenberg LG, Lemmens VE, Rutten HJ, Creemers GJ, de Hingh IH. Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases. Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2016;42(6):794\u2013800.","journal-title":"Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"issue":"11","key":"16073_CR40","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1111\/codi.15880","volume":"23","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Qin X, Chen W, Liu D, Luo J, Wang H, et al. Risk factors for developing peritoneal metastases after curative surgery for colorectal cancer: a systematic review and meta-analysis. Colorectal disease: official J Association Coloproctology Great Br Irel. 2021;23(11):2846\u201358.","journal-title":"Colorectal disease: official J Association Coloproctology Great Br Irel"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16073-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16073-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16073-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:57:25Z","timestamp":1780959445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16073-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16073"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16073-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Beijing Hospital Ethics Review Committee, National Center of Gerontology (approval number: 2025BJYYEC-KY191-01). All research was conducted in accordance with the Declaration of Helsinki and Istanbul. Due to the retrospective nature of the study, written informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"729"}}